» Articles » PMID: 17336041

JWA As a Functional Molecule to Regulate Cancer Cells Migration Via MAPK Cascades and F-actin Cytoskeleton

Overview
Journal Cell Signal
Date 2007 Mar 6
PMID 17336041
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen activated protein kinase (MAPK) cascades are thought to mediate diverse biological functions such as cell growth, differentiation and migration. Activated MAPK may affect microtubule (MT) which is essential for cellular polarity, differentiation and motility. Data in this study show that JWA, a newly identified novel microtubule-associated protein (MAP) was essential for the rearrangement of F-actin cytoskeleton and activation of MAPK cascades induced by arsenic trioxide (As2O3) and phorbol ester (PMA). Over-expression of JWA alone in HeLa, B16 and HCCLM3 cancer cells effectively inhibited cellular migration; whereas, cellular migration was significantly accelerated when cells were deficient in JWA expression. The mechanism underlying these phenomena might be due to JWA affected F-actin rearrangement. Furthermore, JWA deficiency blocked anti-migratory effect produced by As2O3 but enhanced the migratory effect initiated by PMA in HeLa cells. JWA SDR-SLR motifs are not only critical for the MAPK cascades activation, but also for cell migration. Further studies found that JWA differentially regulated cell migration via ERK downstream effectors focal adhesion kinase (FAK) and cyclooxygenase-2 (COX-2). Therefore, JWA regulated-tumor cellular migration might involve MAPK cascades activation and F-actin cytoskeleton rearrangement mechanisms. Our data provide an unexpected role for JWA in tumor cell migration behaviors.

Citing Articles

PRAF2 is an oncogene acting to promote the proliferation and invasion of breast cancer cells.

Wang Y, Zhao Z, Jiao W, Yin Z, Zhao W, Bo H Exp Ther Med. 2022; 24(6):738.

PMID: 36478884 PMC: 9716117. DOI: 10.3892/etm.2022.11674.


Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery.

Ding K, Liu X, Wang L, Zou L, Jiang X, Li A Cancers (Basel). 2022; 14(19).

PMID: 36230577 PMC: 9564207. DOI: 10.3390/cancers14194655.


participates the maintenance of intestinal epithelial homeostasis via ERK/FBXW7-mediated NOTCH1/PPARγ/STAT5 axis and acts as a novel putative aging related gene.

Li X, Liu J, Zhou Y, Wang L, Wen Y, Ding K Int J Biol Sci. 2022; 18(14):5503-5521.

PMID: 36147468 PMC: 9461671. DOI: 10.7150/ijbs.72751.


ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma.

Kim J, Bahar E, Lee J, Chang S, Kim S, Park E Cell Death Dis. 2022; 13(3):239.

PMID: 35293383 PMC: 8924236. DOI: 10.1038/s41419-022-04568-4.


Glycolysis in the progression of pancreatic cancer.

Chang X, Liu X, Wang H, Yang X, Gu Y Am J Cancer Res. 2022; 12(2):861-872.

PMID: 35261808 PMC: 8900001.